Tri Locum Partners LP
NEW YORK, NY · CIK 1826434 · 13F filing filed 2026-08-14
SEC-registered investment adviser since 2020 · limited partnership
- Assets managed$1.1bn
- Staff8 · 6 in investment roles
- Main clients (by assets)Private funds 64%, Sovereign wealth funds 36%
- Private funds1 (1 hedge) · $127.8m gross assets
- Form ADV · 2026-04-06SEC adviser record
- Kindhedge funds, futures
- Others nearbyNew York, NY
As an employer
- Offices in1 country
- Private fundshedge 1
US visa salary filings
- Filings FY20252
- Median salary offered$166,685
- Middle half$150,028 – $183,342
- Job titles2
| Job title | Filings | Median |
|---|---|---|
| Senior AnalystNew York, NY | 1 | $200,000 |
| Research AssociateNew York, NY | 1 | $133,370 |
Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Tri Locum Partners LP.
$813.2m
reported value
+14.1% vs Q1 2026
19positions
80.0%in top 10
5 new
8 added
6 reduced
3 sold out
vs Q1 2026
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| JOHNSON & JOHNSON JNJ | $107.9m13.27% | Added +10.4k |
| VERTEX PHARMACEUTICALS INC VRTX | $100.2m12.33% | Added +72.5k |
| ELI LILLY & CO LLY | $91.8m11.29% | Added +14.7k |
| ASCENDIS PHARMA A/S ASND | $69.0m8.49% | New |
| DEXCOM INC DXCM | $55.3m6.80% | Added +122.3k |
| AXSOME THERAPEUTICS INC AXSM | $53.7m6.60% | Added +157.2k |
| JAZZ PHARMACEUTICALS PLC JAZZ | $53.4m6.57% | Added +63.1k |
| ENLIVEN THERAPEUTICS INC ELVN | $44.0m5.41% | New |
| ARGENX SE ARGX | $38.6m4.75% | Added +10.0k |
| MADRIGAL PHARMACEUTICALS INC MDGL | $36.7m4.51% | Reduced -35.0k |
| REVOLUTION MEDICINES INC RVMD | $28.4m3.50% | New |
| UNITED THERAPEUTICS CORP DEL UTHR | $25.5m3.13% | Reduced -23.3k |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | $25.3m3.11% | Reduced -274.2k |
| TARSUS PHARMACEUTICALS INC TARS | $20.7m2.54% | Added +75.8k |
| INTUITIVE SURGICAL INC ISRG | $19.1m2.35% | Reduced -105.3k |
| CYTOKINETICS INC CYTK | $16.5m2.03% | New |
| DIANTHUS THERAPEUTICS INC DNTH | $11.8m1.45% | Reduced -24.8k |
| BETA BIONICS INC BBNX | $7.7m0.95% | New |
| DEFINIUM THERAPEUTICS INC DFTX | $7.7m0.94% | Reduced -206.6k |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| THERMO FISHER SCIENTIFIC INC TMO | $65.1m132.4k shares |
| ASCENDIS PHARMA A/S | $58.4m255.3k shares |
| NUVALENT INC | $31.6m308.5k shares |